Handelsbanken Fonder Ab Novo Cure LTD Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Novo Cure LTD stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 34,223 shares of NVCR stock, worth $606,773. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,223
Previous 29,223
17.11%
Holding current value
$606,773
Previous $501,000
6.79%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$215 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$210 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$140 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$76.4 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$53.7 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.86B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...